Breaking News, Promotions & Moves

Biogen Appoints Value-Based Medicine VP

Rudick bring expertise in MS programs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Richard (Rick) A. Rudick, M.D., has been appointed vice president of Development Sciences, Value-Based Medicine, at Biogen Idec. He reports to Alfred Sandrock, M.D., Ph.D., group senior vice president and chief medical officer.   Dr. Rudick will lead the newly created Value-Based Medicine Group that focuses on using new technology to develop innovative programs and tools to better understand, measure and manage the treatment of multiple sclerosis (MS). The group emphasizes more evidence-based, i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters